FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine

Dannel Yeo(The University of Melbourne), Mehrdad Nikfarjam(Austin Health)
BMC Cancer
January 16, 2016
Cited by 53


Related Papers